Inpart Logo
LoginRegister
ICO
Closed:

Seeking Druggable Targets and Technologies to Monitor Glomerular Filtration Rate in Chronic Kidney Disease and Acute Kidney Injury

Header

Johnson & Johnson, a global pharmaceutical company with cutting-edge capabilities in drug development and a history of successful academic collaborations wishes to identify druggable targets in Chronic Kidney Disease and Acute Kidney Injury.

Research Interests

  • Chronic Kidney Disease: Mechanisms of action that reduce proteinuria by enhancing podocyte/endothelial integrity, reduce renal inflammation/fibrosis, and/or enhance tissue regeneration
  • Acute Kidney Injury: Opportunities associated with clinical stage assets are of high interest
  • Acute Kidney Injury...

Opportunity types being sought:

  • Technology

  • Academic Researcher

  • Centre of Excellence

  • Research Project

  • Spinout Company

To see the full details and submit your response please register now.

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile
Powered ByInpart
An online matchmaking platform for university-industry collaboration. Learn More

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.